| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioxcel Therapeutics, Inc. (BTAI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. BTAI is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Mehta Vimal92 | CEO And President | Sale+OE | 2,134 | $1.28 | $2,738.99 | -4.3% | -51.9% | -92.3% | |
| Jun 17, 2024 | Yocca Frank88 | Chief Scientific Officer | Sale+OE | 372 | $1.28 | $476.16 | -2.7% | -51.9% | -92.3% | |
| Jun 5, 2024 | Mehta Vimal92 | CEO And President | Sell | 1,427,494 | $0.28 | $405,135.01 | -5.7% | -62.0% | -94.1% | |
| Apr 4, 2024 | Wiley Matthew T.82 | Chief Commercial Officer | Sale+OE | 1,008 | $2.64 | $2,656.18 | -25.2% | -59.9% | -96.2% | |
| Apr 4, 2024 | Yocca Frank88 | Chief Scientific Officer | Sale+OE | 1,067 | $2.64 | $2,811.54 | -7.7% | -59.9% | -96.2% | |
| Apr 4, 2024 | Mehta Vimal92 | CEO And President | Sale+OE | 5,268 | $2.62 | $13,823.02 | -5.4% | -59.9% | -96.2% | |
| Apr 4, 2024 | O'Neill Vincent86 | See Remarks | Sale+OE | 165 | $2.62 | $432.48 | -3.0% | -59.9% | -96.2% | |
| Apr 4, 2024 | Steinhart Richard I87 | Chief Financial Officer | Sale+OE | 1,069 | $2.64 | $2,816.81 | -18.3% | -59.9% | -96.2% | |
| Apr 4, 2024 | Rodriguez Javier87 | See Remarks | Sale+OE | 1,012 | $2.64 | $2,667.43 | -11.7% | -59.9% | -96.2% | |
| Jun 16, 2023 | Mehta Vimal92 | CEO And President | Sale+OE | 60,000 | $20.86 | $1,251,726.98 | -22.0% | -83.0% | -93.2% |